The World Health Organization (WHO) today confirmed China's latest H7N9 influenza case, in a 67-year-old farmer from Zhejiang province, and said the man is in critical condition.
The WHO said the patient, whose case was reported by the media yesterday, had contact with poultry. He got sick on Oct 16, was admitted to local hospital 2 days later, and was transferred to another hospital on Oct 21 as his condition worsened.
At a malaria conference in South Africa today, researchers reported more promising findings for a vaccine that is furthest along in development, and GlaxoSmithKline (GSK) officials said they now intend to submit a regulatory application for it to the European Medicines Agency (EMA) in 2014, according to a company press release.
A two-drug combination may be effective against Middle East respiratory syndrome coronavirus (MERS-CoV), according to the results of a cell-culture study published today in the Journal of Infection.
Ten new polio cases have been confirmed in Pakistan's North Waziristan region, bringing to 25 the number of cases reported this year, Pakistan Today reported today.
The US government will maintain its supply of anthrax antitoxin through 2018 under Project BioShield contracts issued by the Department of Health and Human Services' (HHS's) Office of the Assistant Secretary for Preparedness and Response (ASPR), the HHS said in a news release yesterday.
The United Nations Food and Agriculture Organization (FAO) today announced two emergency regional projects aimed at detecting and containing H7N9 avian flu in Southeast Asia, the agency said in a press release.
The tests could be used for detection and to help in drug development.
South Korean researchers reported today that they have isolated variant H3N2 influenza (H3N2v) viruses in pigs outside of North America for the first time, and they also isolated novel reassortant swine H3N1 viruses that have 2009 pandemic H1N1 (pH1N1)–derived genes.
Two global groups weighed in today on a new study that found evidence that camels in two regions have antibodies to Middle Eastern respiratory syndrome coronavirus (MERS-CoV) or a close relative.
A virus-like particle (VLP) vaccine for H7N9 avian flu protected mice against the virus in a challenge trial, Novavax Inc. reported in a Jul 26 article in Vaccine.
